Adherence to guidelines on empiric use of antibiotics in the emergency room

Infection

Volumn 36, Issue 5, 2008, Pages 408-414

  Galayduyk, N ^a   Colodner, R ^a   Chazan, B ^a,b   Flatau, E ^a,c   Lavi, I ^d   Raz, R ^a,c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; ROXITHROMYCIN;

AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CATHETER; CELLULITIS; COMMUNITY ACQUIRED PNEUMONIA; DEMOGRAPHY; DISEASE SEVERITY; DRUG UTILIZATION; EMERGENCY PHYSICIAN; EMERGENCY TREATMENT; EMERGENCY WARD; ERYSIPELAS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT RESPONSE; URINE CULTURE; WARD;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFECTION; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 56549127128     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-6306-1     Document Type: Article

References (27)

1. Paterson DL: The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006; 42: S90-S95.
2. Cosgrove SE: The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay and health care costs. Clin Infect Dis 2006; 42: S82-S89.
3. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH: Infectious Diseases Society of America: practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35: 113-125.
4. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37: 1405-1433.
5. American Thoracic Society: Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Resp Crit Care Med 2001; 163: 1730-1754.
6. Naber KG, Bergman B, Bishop MC, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001; 40: 576-588.
7. Harvey K, Stewart R, Hemming M, Moulds R: Use of antibiotic agents in a large teaching hospital - the impact of Antibiotic Guidelines. Med J Austr 1983; 2: 217-221.
8. Berild D, Ringertz SH, Lelek M, Fosse B: Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a university hospital. Scand J Infect Dis 2001; 33: 63-67.
9. Garau J: Have guidelines had an impact on antimicrobial resistance? Semin Respir Infect 2001; 16: 210-214.
10. Natsch S, Kullberg BJ, van der Meer JW, Meis JF: Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 1998; 17: 681-684.
11. Stephan F, Sax H, Wachsmuth M, Hoffmeyer P, Clergue F, Pittet D: Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study. Clin Infect Dis 2006; 42: 1544-1551.
12. Di Giammarino L, Bihl F, Bissig M, Bernasconi B, Cerny A, Bernasconi E: Evaluation of prescription practices of antibiotics in a medium-sized Swiss Hospital. Swiss Med Wkly 2005; 135: 710-714.
13. Arnold FW, McDonald LC, Smith RS, Newman D, Ramirez JA: Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol 2006; 27: 378-382.
14. Arnaud I, Elkouri D, N'Guyen JM, et al. Local guidelines and quality of antibiotic treatment in urinary tract infections: a clinical audit in two departments of a university hospital. Presse Med 2005; 34: 1697-1702.
15. Ali MH, Kalima P, Maxwell SR: Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centers. J Antimicrob Chemother 2006; 57: 959-962.
16. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155.
17. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D: Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-535.
18. Hanon F-X, Monnet DL, Sorensen TL, Molbak K, Pedersen G, Schonheyder H: Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis 2002; 34: 520-528.
19. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik S: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-386.
20. Menendez R, Ferrando D, Valles JM, Vallterra J: Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122: 612-617.
21. Mortensen EM, Restrepo M, Anzueto A, Pugh J: Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 2004; 117: 726-731.
22. Bodi M, Rodriguez A, Sole-Violan J, et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005; 41: 1709-1716.
23. Marras TK, Jamieson L, Chan CK: Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals. Can Respir J 2004; 11: 131-137.
24. Lodise TP, McKinnon PS, Swiderski L, Ryback MJ: Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423.
25. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB: Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25: 181-185.
26. Kim SH, Park WB, Lee KD, et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004; 54: 489-497.
27. Wilson PA, Ferguson J: Severe community-acquired pneumonia: an Australian perspective. Intern Med J 2005; 35: 699-705.